OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance of Being PI3K in the RAS Signaling Network
Cristina Cuesta, Cristina Arévalo-Alameda, Esther Castellano
Genes (2021) Vol. 12, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Cell–cell communication: new insights and clinical implications
Jimeng Su, Ying Song, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27

Allostery, and how to define and measure signal transduction
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Biophysical Chemistry (2022) Vol. 283, pp. 106766-106766
Open Access | Times Cited: 36

Aflatoxin B1 disrupts testicular development via the cell cycle-related Ras/PI3K/Akt signaling in mice and pig
Fa‐Li Zhang, Hao‐Hai Ma, Pei-Yu Dong, et al.
Environmental Pollution (2023) Vol. 329, pp. 121729-121729
Closed Access | Times Cited: 21

RAS-activated PI3K/AKT signaling sustains cellular senescence via P53/P21 axis in experimental models of psoriasis
Laura Mercurio, Jacob T. Bailey, Adam B. Glick, et al.
Journal of Dermatological Science (2024) Vol. 115, Iss. 1, pp. 21-32
Closed Access | Times Cited: 7

Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4

Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
Shaimaa Khattab, Adriatik Berisha, Natalia Baran, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 202-202
Open Access

Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways
Ahmed S. Doghish, Sherif S. Abdel Mageed, Mohamed Bakr Zaki, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Targeting PI3K signaling in Lung Cancer: advances, challenges and therapeutic opportunities
Bitian Zhang, Ping‐Chung Leung, William C. Cho, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Therapeutic Effect of Cisplatin-Loaded Polymeric Nanoparticles and Nimotuzumab Combination in Human Glioblastoma Cells
Elif Kağa, Serhat Korkmaz, Sadık Kağa
Research Square (Research Square) (2025)
Closed Access

RAS Pathway Mutations and Therapeutics in Vascular Anomalies
Sara Alharbi, Svatava Merkle, Adrienne M. Hammill, et al.
Pediatric Blood & Cancer (2025)
Open Access

Cell membrane sialome machinery and regulation of receptor tyrosine kinases in gliomas: The functional relevance and therapeutic perspectives
Patrycja Jastrząb, Halina Car, Przemysław Wielgat
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117921-117921
Closed Access

Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes
Munier Hossain, Md. Arafat Hossain
European Journal of Pharmacology (2025), pp. 177432-177432
Closed Access

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
Pankaj Garg, Sravani Ramisetty, Meera G. Nair, et al.
Biochemical Pharmacology (2025), pp. 116850-116850
Open Access

Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers
D. Manikandan, Sankar Jagadeeshan, Sooraj Mathukkada, et al.
Neoplasia (2025) Vol. 63, pp. 101157-101157
Closed Access

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 666-666
Open Access | Times Cited: 20

Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit
Wenjuan Ning, Thomas M. Marti, Patrick Dorn, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16

Chuanxiong improves angiogenesis via the PI3K/AKT/Ras/MAPK pathway based on network pharmacology and DESI-MSI metabolomics
Xue-Hao Cheng, Xuexin Yang, Herong Cui, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
Joshua Zhang, Lily Darman, Mohammad Rashedul Hassan, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 9

Human dental pulp stem cells derived extracellular matrix promotes mineralization via Hippo and Wnt pathways
Chatvadee Kornsuthisopon, Nunthawan Nowwarote, Ajjima Chansaenroj, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
Ryo Tamura, Kosuke Yoshihara, Takayuki Enomoto
Cancers (2022) Vol. 14, Iss. 9, pp. 2125-2125
Open Access | Times Cited: 14

Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer’s disease: Critical role of the restoration of neuronal circuits
Pinky Pinky, Neha Neha, Mubashshir Ali, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102069-102069
Closed Access | Times Cited: 8

Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma
Sankar Jagadeeshan, Kushal Suryamohan, Nara Shin, et al.
Oral Oncology (2024) Vol. 149, pp. 106688-106688
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top